A pan-cancer and single-cell sequencing analysis of CD161, a promising onco-immunological biomarker in tumor microenvironment and immunotherapy.

Frontiers in immunology(2022)

引用 0|浏览6
暂无评分
摘要
CD161 is involved in the immune infiltration of T cells and macrophages and might be a promising target for tumor immunotherapy.
更多
查看译文
关键词
CD161,T cells,immunotherapy,macrophages,mutation,pan-cancer,prognosis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要